home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Amyloid Inhibitors Are Aggregates Too

  February, 7 2008 10:09
your information resource in human molecular genetics

A new understanding of the way protein inhibitors work may have major implications in the development of drugs for Alzheimer's and other neurodegenerative diseases. Scientists have discovered a significant feature in the way that known amyloid inhibitors work, according to a paper to be published online this week in Nature Chemical Biology.

Several neurodegenerative diseases may be caused by the collection of various proteins into large clumps of disordered proteins, known as fibrils. A common strategy to try to find cures for these diseases is to search for molecules that can prevent formation of these fibrils or even cause them to break apart.

Brian Shoichet and colleagues demonstrate that the molecules that have been identified so far in this search act in an unusual manner: the compounds themselves form large groups, known as aggregates, which then act on the proteins to prevent the undesired clumping. The authors also found that other compounds not previously identified as amyloid inhibitors but known to form aggregates also stop the proteins from clumping up. This result will require a significant re-evaluation of the way in which drug developers approach Alzheimer's disease.

Author contact:

Brian Shoichet (University of California San Francisco, San Francisco, CA. USA)
E-mail: shoichet@cgl.ucsf.edu

Abstract available online.

(C) Nature Chemical Biology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.